UH Neurological Institute
Showing of 35 results

May is American Stroke Month: University Hospitals Offering Free Screenings and Educational Events
University Hospitals Neurological Institute is offering the community peace of mind with free stroke screenings, educational events and health talks with neurologists.

UH Cleveland Medical Center Currently Recruiting People with Early Alzheimer’s Disease for a Clinical Trial Evaluating Benfotiamine, a Synthetic Version of Thiamine (Vitamin B1)
Phase 2 study funded by the National Institute on Aging, part of the NIH, is evaluating effects of benfotiamine on cognitive function.

University Hospitals Now Offering Ultra-Minimally Invasive Endoscopic Spine Surgery for Patients Experiencing Back Pain
UH is the only health system in the Greater Cleveland area offering this unique surgery for herniated discs.

University Hospitals Awarded $7 Million by PCORI to Study Endovascular Thrombectomy in Patients Presenting Beyond 24 Hours
Dr. Amrou Sarraj will lead the study, which aims to provide deterministic evidence of clinical benefit due to addition of endovascular thrombectomy to standard medical care in this population.

University Hospitals Only Health System in Northeast Ohio Offering FDA-Approved KISUNLA™ for Treatment of Alzheimer’s Disease
UH Brain Health & Memory Center Begins KISUNLA (Donanemab) Infusions for Patients.

University Hospitals Nationally Recognized for High-Quality Stroke Care
The American Heart Association presents Get With The Guidelines® - Stroke awards for proven dedication to ensuring all stroke patients have access to best practices and life-saving care.

Two UH Physician-Scientists to Receive 2024 Top Ten Clinical Research Achievement Awards
Mehdi Shishehbor, DO, MPH, PhD, and Amrou Sarraj, MD, will receive honors from the Clinical Research Forum in a ceremony to be held April 2 in Las Vegas.

International Study Finds Thrombectomy Highly Effective Long-Term Treatment for Large Strokes
Led by University Hospitals stroke director Amrou Sarraj, MD, SELECT2 study results in The Lancet presented at International Stroke Conference.